Company: IXHL
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029414
Chunk: 12

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 12
---
 Act”), and may remain an emerging
growth company until December 31, 2026, or until such earlier time as we have more than $1.235 billion in annual revenue, we become a
“large accelerated filer” under SEC rules, or we issue more than $1 billion of non-convertible debt over a three-year period.
The JOBS Act contains provisions that, among other things, reduce certain reporting requirements for an “emerging growth company.”
For so long as we remain an emerging growth company, we are permitted and plan to rely on exemptions from certain disclosure requirements
that are applicable to other public companies that are not emerging growth companies.

These exemptions include
reduced disclosure obligations regarding executive compensation. In addition, as an emerging growth company, we are not required to conduct
votes seeking approval, on an advisory basis, of the compensation of our named executive officers or the frequency with which such votes
must be conducted. We may take advantage of some or all of these exemptions until such time as we are no longer an emerging growth company.

We are also a “smaller
reporting company,” meaning that the market value of our stock held by non-affiliates is less than $700 million and our annual revenue
was less than $100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either
(i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million
during the most recently completed fiscal year and the market value of our stock held by non-affiliates was less than $700 million. If
we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain
disclosure requirements that are available to smaller reporting companies. For so long as we remain a smaller reporting company, we are
permitted and intend to rely on exemptions from certain disclosure and other requirements that are applicable to other public companies
that are not applicable to a smaller reporting company.

Additional Information

For additional information
related to our business and operations, please refer to the reports incorporated herein by reference, as described under the caption
“Incorporation of Certain Documents by Reference” on page 27 of this prospectus.

<div align='center'>S-4</div>

THE OFFERING

| Common Stock offered by us                                  | Shares of our common stock having an aggregate offering price of up to